Subsequently, Tzartzeva et al. performed a meta-analysis of 32 studies, reporting that ultrasound alone had a sensitivity of 84% for detecting any-stage HCC, but only 47% for early-stage HCC, and that the addition of AFP increased early detection sensitivity to 63%, still leaving a significant diagnostic gap [45]. Here, AFP is linked to hepatocellular carcinoma.